Back to Search
Start Over
Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners' and patient's perception.
Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners' and patient's perception.
- Source :
-
Journal of voice : official journal of the Voice Foundation [J Voice] 2012 Sep; Vol. 26 (5), pp. 664.e25-33. Date of Electronic Publication: 2011 Dec 29. - Publication Year :
- 2012
-
Abstract
- Objectives: Perceptual judgments and patients' perception of voice and speech after concurrent chemoradiotherapy (CCRT) for advanced head and neck cancer.<br />Study Design: Prospective clinical trial.<br />Methods: A standard Dutch text and a diadochokinetic task were recorded. Expert listeners rated voice and speech quality (based on Grade, Roughness, Breathiness, Asthenia, and Strain), articulation (overall, [p], [t], [k]), and comparative mean opinion scores of voice and speech at three assessment points calculated. A structured study-specific questionnaire evaluated patients' perception pretreatment (N=55), at 10-week (N=49) and 1-year posttreatment (N=37).<br />Results: At 10 weeks, perceptual voice quality is significantly affected. The parameters overall voice quality (mean, -0.24; P=0.008), strain (mean, -0.12; P=0.012), nasality (mean, -0.08; P=0.009), roughness (mean, -0.22; P=0.001), and pitch (mean, -0.03; P=0.041) improved over time but not beyond baseline levels, except for asthenia at 1-year posttreatment (voice is less asthenic than at baseline; mean, +0.20; P=0.03). Perceptual analyses of articulation showed no significant differences. Patients judge their voice quality as good (score, 18/20) at all assessment points, but at 1-year posttreatment, most of them (70%) judge their "voice not as it used to be." In the 1-year versus 10-week posttreatment comparison, the larynx-hypopharynx tumor group was more strained, whereas nonlarynx tumor voices were judged less strained (mean, -0.33 and +0.07, respectively; P=0.031). Patients' perceived changes in voice and speech quality at 10-week post- versus pretreatment correlate weakly with expert judgments.<br />Conclusion: Overall, perceptual CCRT effects on voice and speech seem to peak at 10-week posttreatment but level off at 1-year posttreatment. However, at that assessment point, most patients still perceive their voice as different from baseline.<br /> (Copyright © 2012 The Voice Foundation. Published by Mosby, Inc. All rights reserved.)
- Subjects :
- Adult
Aged
Antineoplastic Agents administration & dosage
Antineoplastic Agents adverse effects
Cisplatin administration & dosage
Cisplatin adverse effects
Exercise Therapy
Female
Head and Neck Neoplasms complications
Head and Neck Neoplasms drug therapy
Head and Neck Neoplasms pathology
Head and Neck Neoplasms psychology
Head and Neck Neoplasms radiotherapy
Humans
Infusions, Intravenous
Judgment
Male
Middle Aged
Prospective Studies
Radiation Injuries psychology
Radiotherapy, Intensity-Modulated adverse effects
Speech Production Measurement
Surveys and Questionnaires
Time Factors
Treatment Outcome
Voice Disorders chemically induced
Voice Disorders psychology
Chemoradiotherapy adverse effects
Head and Neck Neoplasms therapy
Patients psychology
Radiation Injuries etiology
Speech Acoustics
Speech Perception
Voice Disorders etiology
Voice Quality drug effects
Voice Quality radiation effects
Subjects
Details
- Language :
- English
- ISSN :
- 1873-4588
- Volume :
- 26
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of voice : official journal of the Voice Foundation
- Publication Type :
- Academic Journal
- Accession number :
- 22209059
- Full Text :
- https://doi.org/10.1016/j.jvoice.2011.08.016